3,4-Isopropylidenedioxyamphetamine

IDA
Clinical data
Other names	IDA; Isopropylidenedioxyamphetamine
Drug class	Monoamine releasing agent; Entactogen; Serotonergic psychedelic; Hallucinogen
ATC code	None;
Identifiers
	IUPAC name 1-(2,2-dimethyl-1,3-benzodioxol-5-yl)propan-2-amine;
PubChem CID	130544;
ChemSpider	115480;
ChEMBL	ChEMBL3250329;
Chemical and physical data
Formula	C12H17NO2
Molar mass	207.273 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC(CC1=CC2=C(C=C1)OC(O2)(C)C)N;
	InChI InChI=1S/C12H17NO2/c1-8(13)6-9-4-5-10-11(7-9)15-12(2,3)14-10/h4-5,7-8H,6,13H2,1-3H3; Key:HJMCSQZYQOFDAL-UHFFFAOYSA-N;

3,4-Isopropylidenedioxyamphetamine (IDA) is a monoamine releasing agent (MRA) of the amphetamine family related to 3,4-methylenedioxyamphetamine (MDA) developed by David E. Nichols and colleagues. It is considerably less potent than MDA as an MRA in vitro. IDA fully substituted for MDMA and LSD in animal drug discrimination tests, albeit with 5- to 7-fold lower potency than MDA.